• Innovative form of enteric microcapsules
• Support for the proper intestinal bacterial flora
• Increased absorption of macroelements
• Indispensable element of intestinal homeostasis
• Regeneration of the intestinal mucosa
• Reduced IBS symptoms
• Anti-inflammatory effect
• After antibiotic therapy

Aliness Sodium Butyrate, 550 mg (Butyric acid 170 mg) is a diet supplement containing sodium butyrate, a source of butyric acid – a key energy material for the for epithelial cells of the small and large intestines. Sodium butyrate is a safe and well-tolerated compound with proven beneficial influence on the human gastrointestinal tract.

The formulation is contained in an innovative form of enteric microcapsules that protect butyric acid against the destructive effects of digestive enzymes in the upper part of the gastrointestinal tract and gradually release the substance at the target site – along the whole length of the intestines.

Customers about the product

show all reviews for this product

I was recommended this product as part of the fight against my gut problems. it's nice that the product is vegan.

12/07/2021 maciek

Sodium butyrate, i.e. butyric acid sodium salt, is a butyric acid source. Butyric (butane) acid is a saturated acid belonging to the group of short-chain fatty acids (SCFA), present in the large intestine. As a result of diseases and disorders of the gastrointestinal tract, the amount of butyric acid produced can be significantly reduced. A diet with a small amount of fiber also depletes endogenous butyrate resources.

SCFA are the basic source of energy for intestinal epithelial cells. Naturally, these compounds are formed in the large intestine due to anaerobic bacterial fermentation of dietary fiber. Along with butyric acid, acetic and propionic acid are also members of the SCFA. Of these compounds, butyrate is the most important source of energy for colonocytes. SCFA perform many functions in the digestive tract – they participate in the regulation of intestinal pH, improve the absorption of magnesium, calcium and iron, and beneficially influence the glucose metabolism. They promote the growth of useful intestinal bacterial flora, while inhibiting the growth of potentially pathogenic bacteria, including E. coli and Salmonella.

Sodium butyrate is a key ingredient in intestinal homeostasis. It is indispensable for optimal regeneration of intestinal epithelial cells. Sodium butyrate positively affects the minimization of hypersensitivity of intestinal receptors, regulation of intestinal neurotransmission and intestinal peristalsis.

Sodium butyrate is effective in reducing the symptoms associated with the Irritable Bowel Syndrome (IBS). Butyrate has a normalizing effect in functional bowel disorders, which include IBS. Numerous clinical studies have shown a decreased level of butyrate in people suffering from diarrheic form of IBS. While studying the effect of butyric acid on IBS symptoms, pain reduction was confirmed, including the pain after eating and during defecation. The best effects are visible during long-term use of butyrate. In studies, the effectiveness of supplementation was observed after a 3-month course. Sodium butyrate is a perfect complement to the pharmacological treatment of IBS – the studies showed an improvement in patients’ quality of life.

Butyric acid and other SFCA have an anti-inflammatory effect on the intestinal mucosa. These compounds, and to the biggest extend – butyrate, inhibit the activity of inflammatory mediators in intestinal epithelial cells, including IL-8. Supporting the regeneration, SFCA are helpful in the prevention of inflammatory bowel diseases. Sodium butyrate is recommended in the therapy of numerous inflammatory diseases of the digestive tract – inflammatory bowel diseases or diarrhea of various origins.

Butyric acid and other SFCA play an important role in the prevention of cancer formation process. These compounds, especially butyrate, have the ability to induce apoptosis of altered colonocytes, and because of that they can inhibit the tumor development at an early stage. Butyrate may inhibit the cell cycle of cancer cells. At the same time, butyric acid increases the proliferation of normal epithelial cells.

To sum up, Aliness Sodium Butyrate, 550 mg (Butyric acid 170 mg) is a diet supplement in the enteral form, ensuring the desired effects of butyric acid. This formulation is recommended in digestive ailments, in order to restore and regenerate the intestinal mucosa, supplementary in the irritable bowel syndrome, inflammatory diseases of the mucosa, diarrhea of various origins, after antibiotic therapy and in SCFA deficiency states.